Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrika S H Simonsson

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|April 9, 2008
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorptionJustin J Wilkins, Radojka M Savic, Mats O Karlsson, et al.
Frontiers in Pharmacology|May 1, 2023
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug developmentLaurynas Mockeliunas, Alan Faraj, Rob C van Wijk, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 26, 2018
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophiliaMalte Selch Larsen, Rasmus Vestergaard Juul, Andreas Velsing Groth, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2011
Population pharmacokinetics of ethambutol in South African tuberculosis patientsSiv Jönsson, Alistair Davidse, Justin Wilkins, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2017
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction ModelsChunli Chen, Sebastian G Wicha, Gerjo J de Knegt, et al.
Scientific Reports|April 11, 2018
Improving treatment outcome assessment in a mouse tuberculosis modelBas C Mourik, Robin J Svensson, Gerjo J de Knegt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2019
Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene-based FVIIa prophylaxisMalte Selch Larsen, Rasmus Vestergaard Juul, Shannon M Zintner, et al.
Clinical Pharmacokinetics|March 9, 2016
Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical TrialElke H J Krekels, Ronald Niebecker, Mats O Karlsson, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteersSimbarashe P Zvada, Jan-Stefan Van Der Walt, Peter J Smith, et al.
The Journal of Infectious Diseases|May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial SimulationsRobin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|April 9, 2008
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorptionJustin J Wilkins, Radojka M Savic, Mats O Karlsson, et al.
Frontiers in Pharmacology|May 1, 2023
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug developmentLaurynas Mockeliunas, Alan Faraj, Rob C van Wijk, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 26, 2018
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophiliaMalte Selch Larsen, Rasmus Vestergaard Juul, Andreas Velsing Groth, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2011
Population pharmacokinetics of ethambutol in South African tuberculosis patientsSiv Jönsson, Alistair Davidse, Justin Wilkins, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2017
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction ModelsChunli Chen, Sebastian G Wicha, Gerjo J de Knegt, et al.
Scientific Reports|April 11, 2018
Improving treatment outcome assessment in a mouse tuberculosis modelBas C Mourik, Robin J Svensson, Gerjo J de Knegt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2019
Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene-based FVIIa prophylaxisMalte Selch Larsen, Rasmus Vestergaard Juul, Shannon M Zintner, et al.
Clinical Pharmacokinetics|March 9, 2016
Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical TrialElke H J Krekels, Ronald Niebecker, Mats O Karlsson, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteersSimbarashe P Zvada, Jan-Stefan Van Der Walt, Peter J Smith, et al.
The Journal of Infectious Diseases|May 3, 2018
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial SimulationsRobin J Svensson, Elin M Svensson, Rob E Aarnoutse, et al.
Pageof 11